• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

错配修复缺陷的散发性结直肠癌表现出一些特定的形态学特征:273例腺癌中hMLH1和hMSH2蛋白表达与临床病理特征的关系。

Sporadic colorectal cancers with defective mismatch repair display a number of specific morphological characteristics: relationship between the expression of hMLH1 and hMSH2 proteins and clinicopathological features of 273 adenocarcinomas.

作者信息

Chapusot C, Martin L, Mungra N, Rageot D, Bouvier A M, Bonithon Kopp C, Ponnelle T, Faivre J, Piard F

机构信息

Service d'Anatomie Pathologique, CHU Dijon and Registre Bourguignon des Cancers Digestifs, Faculté de Médecine (INSERM EPI 01-06, IFR 100), 7 Boulevard Jeanne d'Arc, 21079 Dijon Cedex, France.

出版信息

Histopathology. 2003 Jul;43(1):40-7. doi: 10.1046/j.1365-2559.2003.01641.x.

DOI:10.1046/j.1365-2559.2003.01641.x
PMID:12823711
Abstract

AIMS

The aim of this study was to assess the independent value of pathological criteria in the diagnosis of mismatch repair (MMR)-defective sporadic colorectal cancers.

METHODS AND RESULTS

Resected colorectal adenocarcinomas (n = 273) were reviewed in order to identify a number of specific morphological features of MMR-defective carcinomas. Of the 273 cases, 35.2% were right-sided and 5.9% were poorly differentiated. Focal extracellular mucin secretion was seen in 5.1% of cases and a stromal follicular reaction in 4.6%. The expression of the two major MMR proteins hMLH1 and hMSH2 was studied by immunohistochemistry. Carcinomas were considered deficient in the MMR system when a loss of nuclear signal in neoplastic cells was observed for one of the proteins. Such an extinction was seen in 37 of the cases (13.6%). The hMLH1 protein was the one most frequently altered (86.5%). After multivariate analysis, three independent factors were significantly associated with MMR deficiency: proximal location [odds ratio (OR) = 9.30; 95% confidence interval (CI) 2.79, 30.98], the presence of a true stromal follicular reaction (OR = 13.60; 95% CI 2.98, 62.00) and poor differentiation (OR = 8.33; 95% CI 1.63, 40.32).

CONCLUSIONS

These results confirm that sporadic colorectal MMR-defective adenocarcinomas display certain specific morphological characteristics. However, these pathological features are not sufficiently predictive and immunohistochemistry is needed to identify such tumours accurately.

摘要

目的

本研究旨在评估病理标准在错配修复(MMR)缺陷型散发性结直肠癌诊断中的独立价值。

方法与结果

回顾性分析273例切除的结直肠腺癌,以确定MMR缺陷型癌的一些特定形态学特征。273例病例中,35.2%为右侧肿瘤,5.9%为低分化肿瘤。5.1%的病例可见局灶性细胞外黏液分泌,4.6%的病例可见间质滤泡反应。采用免疫组织化学方法研究两种主要MMR蛋白hMLH1和hMSH2的表达。当肿瘤细胞中一种蛋白的核信号缺失时,癌被认为存在MMR系统缺陷。37例病例(13.6%)出现这种缺失。hMLH1蛋白是最常发生改变的蛋白(86.5%)。多因素分析后,三个独立因素与MMR缺陷显著相关:肿瘤位于近端[比值比(OR)=9.30;95%置信区间(CI)2.79,30.98]、存在真正的间质滤泡反应(OR = 13.60;95% CI 2.98,62.00)和低分化(OR = 8.33;95% CI 1.63,40.32)。

结论

这些结果证实散发性结直肠MMR缺陷型腺癌具有某些特定的形态学特征。然而,这些病理特征的预测性不足,需要免疫组织化学来准确识别此类肿瘤。

相似文献

1
Sporadic colorectal cancers with defective mismatch repair display a number of specific morphological characteristics: relationship between the expression of hMLH1 and hMSH2 proteins and clinicopathological features of 273 adenocarcinomas.错配修复缺陷的散发性结直肠癌表现出一些特定的形态学特征:273例腺癌中hMLH1和hMSH2蛋白表达与临床病理特征的关系。
Histopathology. 2003 Jul;43(1):40-7. doi: 10.1046/j.1365-2559.2003.01641.x.
2
Histopathology and mismatch repair status of 458 consecutive colorectal carcinomas.458例连续性结直肠癌的组织病理学和错配修复状态
Am J Surg Pathol. 2003 Nov;27(11):1393-406. doi: 10.1097/00000478-200311000-00001.
3
hMLH1 and hMSH2 expression in human hepatocellular carcinoma.人肝细胞癌中hMLH1和hMSH2的表达
Int J Oncol. 2001 Sep;19(3):567-70.
4
Immunohistochemistry for hMLH1 and hMSH2: a practical test for DNA mismatch repair-deficient tumors.hMLH1和hMSH2的免疫组织化学:DNA错配修复缺陷肿瘤的实用检测方法
Am J Surg Pathol. 1999 Oct;23(10):1248-55. doi: 10.1097/00000478-199910000-00010.
5
Expression of hMSH2 and hMLH1 in colorectal carcinomas with microsatellite instability.hMSH2和hMLH1在微卫星不稳定的结直肠癌中的表达
Pathol Res Pract. 1998;194(1):3-9. doi: 10.1016/S0344-0338(98)80006-X.
6
Immunohistochemical pattern of hMSH2/hMLH1 in familial and sporadic colorectal, gastric, endometrial and ovarian carcinomas with instability in microsatellite sequences.微卫星序列不稳定的家族性和散发性结直肠癌、胃癌、子宫内膜癌及卵巢癌中hMSH2/hMLH1的免疫组化模式
Virchows Arch. 2001 Jan;438(1):39-48. doi: 10.1007/s004280000325.
7
Value of immunohistochemical detection of DNA mismatch repair proteins in predicting germline mutation in hereditary colorectal neoplasms.免疫组织化学检测DNA错配修复蛋白在预测遗传性结直肠肿瘤种系突变中的价值
Am J Surg Pathol. 2005 Jan;29(1):96-104. doi: 10.1097/01.pas.0000146009.85309.3b.
8
BAT-26 microsatellite instability does not correlate with the loss of hMLH1 and hMSH2 protein expression in sporadic endometrial cancers.BAT - 26微卫星不稳定性与散发性子宫内膜癌中hMLH1和hMSH2蛋白表达缺失无关。
Oncol Rep. 2003 Jul-Aug;10(4):1039-43.
9
Possible alternative carcinogenesis pathway featuring microsatellite instability in colorectal cancer stroma.在结直肠癌基质中以微卫星不稳定性为特征的可能的替代致癌途径。
Br J Cancer. 2003 Aug 18;89(4):707-12. doi: 10.1038/sj.bjc.6601141.
10
[Diagnostic and prognostic values of repair protein hMLH1, hMSH2 and protein CD34 immunoexpression in sporadic colorectal cancer].[修复蛋白hMLH1、hMSH2及蛋白CD34免疫表达在散发性结直肠癌中的诊断及预后价值]
Pol Merkur Lekarski. 2010 Dec;29(174):351-6.

引用本文的文献

1
HER2 Overexpression and Mismatch Repair Deficiency are Correlated with Malignancy in Colorectal Cancer.人表皮生长因子受体2过表达和错配修复缺陷与结直肠癌的恶性程度相关。
Cancer Manag Res. 2021 Apr 20;13:3443-3454. doi: 10.2147/CMAR.S297596. eCollection 2021.
2
Relationship between MLH-1, MSH-2, PMS-2,MSH-6 expression and clinicopathological features in colorectal cancer.结直肠癌中MLH-1、MSH-2、PMS-2、MSH-6表达与临床病理特征的关系
Int J Clin Exp Pathol. 2015 Apr 1;8(4):4044-53. eCollection 2015.
3
Microsatellite instability testing in Korean patients with colorectal cancer.
韩国结直肠癌患者的微卫星不稳定性检测。
Fam Cancer. 2012 Sep;11(3):459-66. doi: 10.1007/s10689-012-9536-4.
4
A review of the most promising biomarkers in colorectal cancer: one step closer to targeted therapy.结直肠癌最有前途的生物标志物综述:迈向靶向治疗的一步。
Oncologist. 2010;15(7):699-731. doi: 10.1634/theoncologist.2010-0025. Epub 2010 Jun 28.
5
Importance of MutL homologue MLH1 and MutS homologue MSH2 expression in Turkish patients with sporadic colorectal cancer.MutL同源物MLH1和MutS同源物MSH2在土耳其散发性结直肠癌患者中的表达情况
World J Gastroenterol. 2007 Sep 7;13(33):4437-44. doi: 10.3748/wjg.v13.i33.4437.
6
Complementary analysis of microsatellite tumor profile and mismatch repair defects in colorectal carcinomas.结直肠癌微卫星肿瘤谱与错配修复缺陷的互补分析。
World J Gastroenterol. 2006 Oct 7;12(37):5932-40. doi: 10.3748/wjg.v12.i37.5932.